A phase II study of gemcitabine (gemzar, LY188011) in the treatment of recurrent or persistent endometrial carcinoma: A gynecologic oncology group study

2011 ◽  
Vol 121 (1) ◽  
pp. 118-121 ◽  
Author(s):  
David L. Tait ◽  
John A. Blessing ◽  
James S. Hoffman ◽  
Kathleen N. Moore ◽  
Nick M. Spirtos ◽  
...  
2006 ◽  
Vol 103 (2) ◽  
pp. 523-526 ◽  
Author(s):  
Paula M. Fracasso ◽  
John A. Blessing ◽  
Kelly L. Molpus ◽  
Lisa M. Adler ◽  
Joel I. Sorosky ◽  
...  

2011 ◽  
Vol 120 (2) ◽  
pp. 185-188 ◽  
Author(s):  
Allan L. Covens ◽  
Virginia Filiaci ◽  
Deborah Gersell ◽  
Christopher V. Lutman ◽  
Albert Bonebrake ◽  
...  

1993 ◽  
Vol 49 (1) ◽  
pp. 48-50 ◽  
Author(s):  
Gregory P. Sutton ◽  
John A. Blessing ◽  
Philip J. DiSaia ◽  
William P. McGuire

1999 ◽  
Vol 75 (3) ◽  
pp. 473-475 ◽  
Author(s):  
David H. Moore ◽  
John A. Blessing ◽  
Charles Dunton ◽  
Richard E. Buller ◽  
Gary C. Reid

Sign in / Sign up

Export Citation Format

Share Document